bioRxivCell BiologyPreprint
Spatial and Multiomic profiling of muscle regeneration dynamics in Duchenne Muscular Dystrophy
Laura VirtaneniD, Chiara D’ErcoleiD, Lucile SaillardiD, Fiorella Carla GrandiiD, Cécile PeccateiD, Bénédicte Hoareau‐CoudertiD, Vaarany Karunanuthy, Céline Bertholle, Brigitte IzaciD, Benjamin SaintpierreiD, Muriel AndrieuiD, Franck LetourneuriD, Kamel MamchaouiiD, Maud Chapart, Stéphane Vasseur, Piera SmeriglioiD, Teresinha EvangelistaiD, Luca MadaroiD, Lorenzo GiordaniiD
Abstract
Duchenne muscular dystrophy (DMD) is a pediatric degenerative myopathy caused by the absence of functional dystrophin. As a result, DMD muscles exhibit compromised myofiber integrity and increased susceptibility to mechanical damage. In early disease stages, muscles undergo repeated cycles of degeneration and regeneration; over time, however, this regenerative capacity declines, leading to the gradual replacement of muscle tissue with fat and fibrosis. While several signaling pathways have been identified as deregulated in dystrophic muscle, the cellular and molecular mechanisms underlying this regenerative exhaustion remain to be fully elucidated. To address this, we constructed a comprehensive cellular atlas of human dystrophic muscle using high-resolution spatial transcriptomics (Visium HD), capturing the cellular crosstalk within regenerative regions. Cell-to-cell communication analysis revealed activation of Notch signaling mediated by NOTCH3 in activated satellite cells. Immunostaining confirmed elevated NOTCH3 expression in both DMD patient samples and in the mdx mouse model at late disease stages. Silencing of NOTCH3 in primary myoblasts improved myogenic differentiation, pinpointing NOTCH3-mediated signaling as a contributor to regeneration impairment. To further dissect the dynamics of regeneration and infer the gene regulatory networks governing myogenic differentiation, we integrated paired snRNA-seq and snATAC-seq data from young, adult, and aged mdx mice. This analysis identified GLIS3 upregulation as an additional barrier to effective myogenesis. GLIS3 displayed an overall increase in dystrophic muscles, while silencing experiments enhanced differentiation in myoblasts. Together, our work reveals intrinsic defects in the dystrophic stem cell compartment that emerge during disease progression and hinder the execution of the myogenic program. These findings suggest NOTCH3 and GLIS3 as potential therapeutic targets to enhance regeneration and maintain muscle integrity in DMD. This study provides a high-resolution map of the dystrophic regenerative landscape and offers a valuable resource for future translational research.
- organism: mouse
- organism: human
- assay: spatial transcriptomics
- assay: scRNA-seq
- assay: scATAC-seq
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: deep learning
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity
Jules A Granet, Rebecca Robertson, … Natasha C. Chang·Cell Death and DiseasePeer-reviewed·Jun 5, 2025
- Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts
M. R. Gosselin, V. Mournetas, … D. C. Gorecki·bioRxiv·Aug 24, 2021
- Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
D. A. Mazala, R. Hindupur, … J. K. Jaiswal·bioRxiv·Mar 27, 2023
- Impaired stem cell migration and divisions in Duchenne Muscular Dystrophy revealed by live imaging
Liza Sarde, Gaëlle Letort, … Brendan Evano·Nature CommunicationsPeer-reviewed·Jan 28, 2026
- Multi-modal analysis of satellite cells reveals early impairments at pre-contractile stages of myogenesis in Duchenne muscular dystrophy
Sophie Franzmeier, Shounak Chakraborty, … Kaspar Matiasek·CellsPeer-reviewed·Jun 13, 2025
- Epigenetic control of myogenic identity of human muscle stem cells in Duchenne Muscular Dystrophy
Jimmy Massenet, Michèle Weiss‐Gayet, … Bénédicte Chazaud·iSciencePeer-reviewed·Nov 8, 2024